Brazil Gets Record Discount on Bristol Anti-HIV Drug
Brazil's health ministry said Friday it had negotiated a record 76% discount for Bristol-Myers Squibb's new anti-AIDS drug Atazanavir without threatening to strip the drug's patent, according to the Associated Press....To view the full article, register now.
Already a subscriber? Click here to view full article